Comera Life Sciences Holdings, Inc.
Σύμβολο: CMRA
NASDAQ
0.02684
USDΤιμή αγοράς σήμερα
-0.0074
Λόγος P/E
0.0000
Δείκτης PEG
1.17M
MRK Cap
- 0.00%
DIV Απόδοση
Comera Life Sciences Holdings, Inc. (CMRA) Οικονομικές καταστάσεις
Ισολογισμός
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4.23 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0.63 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 3.98 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 1.08 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 9.93 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 1.84 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0.37 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 2.21 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 6.53 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 1.85 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0.17 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 5.52 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 18.92 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0.98 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 34.22 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 13622.31 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0.01 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | -152.04 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -9017.78 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | -4474.58 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 12.14 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | -22.08 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 12.14 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 2.02 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | -2.2 | 0.3 | -6.2 | 0 |
Κατάσταση ταμειακών ροών
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -9.01 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0.1 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | -0.08 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 1 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 1.41 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0.29 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0.51 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | -0.4 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 1 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | -0.08 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | -6.66 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | -28.66 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0.13 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 650 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | -644.28 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.85 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 28.57 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | -0.9 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 5.94 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 6.84 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | -6.66 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | -28.68 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | -35.34 | -9.8 | -3.9 | -1.8 |
Σειρά κατάστασης λογαριασμού αποτελεσμάτων
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0.26 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0.74 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 1.43 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 8.45 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 9.88 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 10.15 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0.15 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0.1 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | -9.07 | - | - | - | |||
income-statement-row.row.operating-income | -9.15 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | -9.01 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 75.23 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | -84.25 | -24 | -5.3 | -2.1 |
Συχνές ερωτήσεις
Ποιο είναι το Comera Life Sciences Holdings, Inc. (CMRA) το σύνολο του ενεργητικού?
Comera Life Sciences Holdings, Inc. (CMRA) το συνολικό ενεργητικό είναι 3727113.000.
Ποια είναι τα ετήσια έσοδα της επιχείρησης?
Τα ετήσια έσοδα είναι 451365.000.
Ποιο είναι το περιθώριο κέρδους της επιχείρησης?
Το περιθώριο κέρδους της επιχείρησης είναι 0.735.
Ποια είναι η ελεύθερη ταμειακή ροή της επιχείρησης?
Η ελεύθερη ταμειακή ροή είναι -1.529.
Ποιο είναι το καθαρό περιθώριο κέρδους της επιχείρησης?
Το καθαρό περιθώριο κέρδους είναι -84.219.
Ποια είναι τα συνολικά έσοδα της επιχείρησης?
Τα συνολικά έσοδα είναι -9.143.
Ποια είναι η Comera Life Sciences Holdings, Inc. (CMRA) καθαρό κέρδος (καθαρό εισόδημα)?
Το καθαρό κέρδος (καθαρό εισόδημα) είναι -24038181.000.
Ποιο είναι το συνολικό χρέος της επιχείρησης?
Το συνολικό χρέος είναι 775048.000.
Ποιος είναι ο αριθμός των λειτουργικών εξόδων?
Τα λειτουργικά έξοδα είναι 12392727.000.
Ποιος είναι ο αριθμός των ταμειακών διαθεσίμων της εταιρείας?
Τα ταμειακά διαθέσιμα της επιχείρησης είναι 1767870.000.